Guangzhou Huffman Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Huffman Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JORIVA. The owner is based in Guangzhou.

Shop 2229, 2nd Floor, South Building of Liuhua Hotel, No. 194 Huanshi West Road, Yuexiu District

Guangzhou Liuhua Clothing Wholesale Market China

Guangzhou 510000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JORIVA
JORIVA
Registered 2025

Trademark Classifications

Guangzhou Huffman Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Guangzhou Huffman Trading Co., Ltd. have?

Guangzhou Huffman Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Huffman Trading Co., Ltd. file in?

Guangzhou Huffman Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 18 (Leather Goods). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.

What are Guangzhou Huffman Trading Co., Ltd.'s most well-known trademarks?

Guangzhou Huffman Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as JORIVA. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Huffman Trading Co., Ltd.'s trademark registration success rate?

Guangzhou Huffman Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.